Tension Headaches vs. Migraines: How the Endocannabinoid System Is Involved in Both

“Headache” is one word doing the work of many conditions. The two most common — tension-type headache and migraine — are routinely confused, yet they arise through different mechanisms and respond to different strategies. Telling them apart is the first step toward addressing either intelligently. And underneath both runs a common biological thread that most discussions miss entirely: the endocannabinoid system — the regulatory network we explore in full in our practitioner’s guide to CBG and headache relief.

If you take nothing else from this article, take the row on nausea and sensory sensitivity: their presence points strongly to migraine, their absence to tension-type headache. That single distinction guides much of what follows.

A tension headache is the most common form of head pain. It typically presents as a dull, pressing, tightening sensation on both sides of the head — the proverbial band cinching around the skull — often radiating into the neck and shoulders. It usually lacks the nausea, throbbing, and sensory sensitivity that define migraine.

Its mechanism is comparatively peripheral, at least early on. Increased sensitivity in the pericranial muscles — the muscles around the skull, jaw, and neck — is a hallmark, and the episodic form is driven mainly by these peripheral, myofascial factors, according to headache pathophysiology research. This is why tension headaches so often trace back to posture, stress-clenched muscles, screen time, and physical tension held in the upper body.

But the chronic form changes character. As tension headache becomes frequent, central mechanisms take over: the nervous system itself becomes sensitized, lowering the pain threshold so that ordinary muscular signals are amplified into pain, in a progression from stress to central sensitization.

Migraine is a different animal. It is a neurovascular condition, most likely originating in the sensory fibers that innervate the blood vessels in and around the brain. The pain is typically throbbing, often one-sided, and frequently accompanied by nausea, vomiting, and pronounced sensitivity to light, sound, and movement. Some experience aura — visual or sensory disturbances — beforehand.

During an attack, peripheral and central sensitization of the trigeminovascular pathway develop, and over time this central sensitization can drive the transformation of occasional migraine into chronic migraine, as central-sensitization research describes. The presence of nausea and sensory sensitivity — absent in tension headache — is one of the clearest clinical distinctions between the two.

Real life is messier than a textbook. Many people experience both kinds of headache, sometimes blurring into a mixed picture. Two complications are worth naming. The first is transformed or chronic daily headache, where frequent episodic headaches gradually merge into a near-constant background ache as central sensitization sets in. The second is medication-overuse headache — the paradox in which frequent use of acute painkillers, more than about ten to fifteen days a month, begins to generate headaches of its own. This is one of the strongest arguments for a root-cause, lower-the-baseline approach rather than escalating reliance on rescue analgesics. It is also why distinguishing your pattern, rather than reaching reflexively for the same pill, matters.

To see why one system can be relevant to two different headaches, it helps to understand what the ECS actually does. It is the body’s volume knob for pain and inflammation. CB1 receptors sit largely on nerve cells, where they dampen the release of pain-signaling neurotransmitters — turning down the signal before it travels. CB2 receptors sit largely on immune cells, where they calm neuroinflammation, the low-grade immune activation that sensitizes pain pathways. The body’s own cannabinoids, anandamide and 2-AG, act on these receptors moment to moment to keep the system in balance, and other targets like TRPV1 help govern how pain and heat are perceived.

When this regulatory tone runs low, the brakes on pain weaken — and that single deficit can express as different headaches depending on the rest of your physiology.

Here is where the two conditions, for all their differences, converge. In their chronic forms, both involve central sensitization — a nervous system whose pain-regulating machinery has been turned up too high. And the system most responsible for keeping that machinery in balance is the endocannabinoid system.

This is the basis of the Clinical Endocannabinoid Deficiency theory, which proposes that an under-active endocannabinoid baseline may characterize migraine and other conditions marked by central sensitization, as a major review reconsidered. Supporting that finding, levels of the endocannabinoid anandamide are reduced in the cerebrospinal fluid and plasma of chronic migraine patients, in clinical measurements.

The implication is significant. Whether your head pain is the muscular band of a tension headache or the neurovascular storm of a migraine, the endocannabinoid system is part of the regulatory picture — which is why cannabinoids that support it are being studied across both. For the root-cause TCM perspective on why this pain rises in the first place, see our guide to Liver Yang rising and chronic headaches. If you are weighing which cannabinoid does what, our comparison of CBG versus CBD breaks it down, and the inflammatory dimension of head pain is covered in our piece on CBG for inflammation.

Look closely and one trigger recurs across both conditions: stress, and the muscular and nervous-system tension it creates. Stress clenches the jaw and the pericranial muscles that feed tension headache. The “let-down” after a stress peak — a Friday evening, the start of a vacation — is a classic migraine trigger. Sleep disruption, itself often stress-driven, aggravates both. This shared root is exactly why the practitioner’s approach emphasizes downshifting the nervous system as a daily practice, not only treating the headache once it has arrived.

Knowing which headache you have changes the approach, and so does knowing whether you are managing an acute episode or a chronic pattern. For tension-type pain rooted in muscular tightness, the priority is addressing the physical driver — the clenched neck, jaw, and shoulders that feed the cycle — with warmth, gentle release, movement breaks, and better posture. For the chronic, recurring side of both headache types, where central sensitization and low endocannabinoid tone are in play, the more durable move is to support the regulatory system itself. A consistent, full-spectrum cannabinoid foundation is one way to do that: the Wellness Tincture is a whole-plant extract — CBG among its naturally-occurring cannabinoids — formulated to support baseline endocannabinoid tone, addressing the system rather than only the symptom. It is third-party lab tested, with a Certificate of Analysis available.

For the patient whose tension pattern resolves in a slow, social evening — not the acute headache pattern that requires retreating to a dark room — the Leisure Gummies are the higher-CBG evening option in the Dragon Hemp lineup. They carry 2mg of CBG added on purpose per gummy, inside a tempered cannabinoid stack with 33mg of CBD and 5mg of hemp-derived, Farm Bill compliant THC. The CBD load tempers the THC. They sit in the non-driving, relaxed-evening category. They are not a migraine-acute treatment or a daytime functional product, and for most patients managing chronic head pain the Calming Gummies remain the right evening choice.

Cannabinoids are not a substitute for proper medical evaluation, and some headaches are warnings rather than nuisances. Seek prompt medical care for a sudden, severe “thunderclap” headache that peaks within seconds; a headache with fever and a stiff neck; one following a head injury; a headache accompanied by confusion, weakness, vision loss, difficulty speaking, or numbness; or the “first or worst” headache of your life. More broadly, any headache that is new after age 50, steadily worsening, or changing in pattern warrants a clinician’s assessment. Recurrent or severe head pain should always be evaluated — the support described here is a wellness approach, not a diagnosis.

The most useful thing I can give a headache sufferer is not another painkiller. It is a clearer map. When you understand that your tension headache lives in the muscles and your migraine lives in the nerves and vessels — and that both run through the same endocannabinoid system that quietly governs how much pain you feel — the path forward stops being guesswork. You address the muscular driver where it lives. You support the regulatory system that has gone quiet. And you stop treating every headache as the same undifferentiated enemy. Precision is its own kind of relief.

Practitioner-Founded.
Rooted in Clinical Expertise.

Dragon Hemp was established by Kevin Menard, LAc, a specialist in Sports Medicine Acupuncture and Traditional Chinese Medicine. Developed in his Sag Harbor clinic, our formulations bridge the gap between ancient herbal wisdom and modern cannabinoid research to address the root causes of pain, sleep, and wellness issues.

From our Rest & Restoration and Essential Wellbeing collections to our targeted Aches & Pains topicals, every product is formulated with organically grown botanicals and premium hemp extracts. We invite you to experience our sophisticated fusion of tradition and innovation at our flagship apothecary at 108 Main Street, Sag Harbor, or explore our full range of tinctures, gummies, and balms online.

• Learn more about our botanicals in our Ingredients Index.
  
  
• Discover the design and ethos of our Sag Harbor apothecary in Forbes.